Camellia and Reduced Lipopolysaccharide-binding Protein/Soluble Cluster of Differentiation-14 Ratio

Doses used in studies

mg/day: 890 (median 890, IQR 890–890) — 1 study

Time to effect

Median: 4 weeks · IQR 4 weeks–4 weeks · Range 4 weeks–4 weeks — Reported in 1 of 1 study

1 of 1 paper

A green tea extract confection decreases circulating endotoxin and fasting glucose by improving gut barrier function but without affecting systemic inflammation: A double-blind, placebo-controlled randomized trial in healthy adults and adults with metabolic syndrome.

2024-04
RCT · n = 21
Nutrition research (New York, N.Y.) 124
- Min Zeng
- Joanna K Hodges
- Avinash Pokala
- Mona Khalafi
- Geoffrey Y Sasaki
- Jillian Pierson
- Sisi Cao
- Guy Brock
- Zhongtang Yu
- Jiangjiang Zhu
- Yael Vodovotz
- Richard S Bruno

PubMed: 38430822
DOI: 10.1016/j.nutres.2024.02.001

13 Insights on

Reduced Lipopolysaccharide-binding Protein/Soluble Cluster of Differentiation-14 Ratio

High evidence
Clinical

No between-treatment differences (P > .05) were observed for plasma tumor necrosis factor-α, interleukin-6, or the ratio of lipopolysaccharide-binding protein/soluble cluster of differentiation-14 affected.

Effect: Neutral
Effect size: Small
Significant: No
Dose: 890 mg/d total catechins